Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma

[1]  H. Mitomi,et al.  Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma. , 2017, Gastrointestinal endoscopy.

[2]  K. Chayama,et al.  Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group , 2017, Journal of Gastroenterology.

[3]  M. Igarashi,et al.  The frequency of early colorectal cancer derived from sessile serrated adenoma/polyps among 1858 serrated polyps from a single institution , 2016, International Journal of Colorectal Disease.

[4]  B. Leggett,et al.  Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma , 2015, Gut.

[5]  Tetsuo Nemoto,et al.  A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study , 2015, Modern Pathology.

[6]  K. Byth,et al.  Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps , 2015, Gut.

[7]  D. McMillan,et al.  The Clinical Utility of the Combination of T Stage and Venous Invasion to Predict Survival in Patients Undergoing Surgery for Colorectal Cancer , 2014, Annals of surgery.

[8]  R. Wada,et al.  Pathological features of the sessile serrated adenoma/polyp with special references of its carcinogenesis , 2014, Medical Molecular Morphology.

[9]  E. Dekker,et al.  Endoscopic characterization of sessile serrated adenomas/polyps with and without dysplasia , 2014, Endoscopy.

[10]  H. Mitomi,et al.  Adenocarcinoma arising in small sessile serrated adenoma/polyp (SSA/P) of the colon: Clinicopathological study of eight lesions , 2014, Pathology international.

[11]  H. Ueno,et al.  Objective criteria for crohn-like lymphoid reaction in colorectal cancer. , 2013, American journal of clinical pathology.

[12]  Deepa T. Patil,et al.  Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status , 2012, Modern Pathology.

[13]  H. Ueno,et al.  Desmoplastic reaction in biopsy specimens of early colorectal cancer: A Japanese prospective multicenter study , 2012, Pathology international.

[14]  Albert C. Koong,et al.  BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features , 2012, The American journal of surgical pathology.

[15]  P. Conesa‐Zamora,et al.  Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma , 2011, Histopathology.

[16]  J. Herman,et al.  Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract , 2011, International journal of cancer.

[17]  D. Chang,et al.  Molecular Features of Colorectal Hyperplastic Polyps and Sessile Serrated Adenoma/Polyps From Korea , 2011, The American journal of surgical pathology.

[18]  M. Mäkinen,et al.  Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma , 2011, Histopathology.

[19]  Y. Oda,et al.  Sessile Serrated Adenoma With Early Neoplastic Progression: A Clinicopathologic and Molecular Study , 2011, The American journal of surgical pathology.

[20]  K. Shirouzu,et al.  Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study , 2011, Journal of Gastroenterology.

[21]  Payal Sipahimalani,et al.  A Histology-Based Model for Predicting Microsatellite Instability in Colorectal Cancers , 2010, The American journal of surgical pathology.

[22]  Colin C Pritchard,et al.  Colorectal cancer molecular biology moves into clinical practice , 2010, Gut.

[23]  R. Genta,et al.  Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients , 2010, Journal of Clinical Pathology.

[24]  E. Montgomery,et al.  Beta-catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates With Early Neoplastic Progression After BRAF Activation , 2009, The American journal of surgical pathology.

[25]  J. Benhattar,et al.  Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps , 2009, Histopathology.

[26]  R. Ward,et al.  Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma , 2009, Journal of Clinical Pathology.

[27]  S. Gruber,et al.  Pathologic Predictors of Microsatellite Instability in Colorectal Cancer , 2009, The American journal of surgical pathology.

[28]  S. Kakar,et al.  Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps , 2008, International journal of cancer.

[29]  John D Potter,et al.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. , 2007, Gastroenterology.

[30]  M. O'brien,et al.  Comparison of Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and KRAS Status in Serrated Polyps and Traditional Adenomas Indicates Separate Pathways to Distinct Colorectal Carcinoma End Points , 2006, The American journal of surgical pathology.

[31]  Rozemary Karamatic,et al.  High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. , 2006, Gastroenterology.

[32]  E. Montgomery,et al.  Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". , 2006, American journal of clinical pathology.

[33]  J. Jass,et al.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer , 2006, Histopathology.

[34]  A. Liakka,et al.  Morphology and microsatellite instability in sporadic serrated and non‐serrated colorectal cancer , 2005, The Journal of pathology.

[35]  R. Wolff,et al.  Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. , 2005, Cancer research.

[36]  E. J. Lee,et al.  Progressive methylation during the serrated neoplasia pathway of the colorectum , 2005, Modern Pathology.

[37]  B. Sis,et al.  Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma , 2004, Journal of Clinical Pathology.

[38]  T. Loy,et al.  Villous Adenocarcinoma of the Colon and Rectum: A Clinicopathologic Study of 36 Cases , 2004, The American journal of surgical pathology.

[39]  N. Matsubara,et al.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.

[40]  I. Stewart,et al.  Histopathology and Mismatch Repair Status of 458 Consecutive Colorectal Carcinomas , 2003, The American journal of surgical pathology.

[41]  Jahn M. Nesland,et al.  Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.

[42]  A. Aldridge,et al.  Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important? , 2001, The European journal of surgery = Acta chirurgica.

[43]  A B West,et al.  Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. , 2001, Gastroenterology.

[44]  A. Rashid,et al.  Histopathological identification of colon cancer with microsatellite instability. , 2001, The American journal of pathology.

[45]  R. Gafà,et al.  Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability , 2000, Cancer.

[46]  C. R. Teixeira,et al.  Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis , 1995, Journal of Gastroenterology.

[47]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[48]  Tsuyoshi Saito,et al.  Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum , 2015, Modern Pathology.

[49]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer , 2011, International Journal of Clinical Oncology.

[50]  N. Goldstein.  Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. , 2006, American journal of clinical pathology.